Clinical Trials

301 enrolled

Breast Diseases, Breast Neoplasms

NCT05802342 2023-04-06

A Multicenter, Randomized, Double-blind Phase II Trial to Evaluate GM1 Prevention of Peripheral Neuropathy in Patients With Breast Cancer

150 enrolled

To Evaluate the Effectiveness of GM1 in the Prevention of Albumin-paclitaxel Therapy Induced Peripheral Neuropathy in Breast Cancer Patients

NCT05103644 2022-11-02

Study of the Therapeutic Effect of Atorvastatin on the Clinical Outcomes in HER2 Negative Breast Cancer Patients"

Breast Neoplasms

NCT05518292 2022-09-28

Comparison of Analgesic Efficacy of Ultrasound Guided Rhomboid Intercostal Block Versus Serratus Anterior Plane Block for Mastectomy Surgery

Breast Neoplasms

NCT04429893 2022-08-02

Magnesium Sulphate to Bupivicaine in Serratus Anterior Plane Block in Modified Radical Mastectomy

80 enrolled

Breast Neoplasms

NCT05253066 2022-02-23

Chidamide Combined With Exemestane (+/- Goserelin) Versus Neoadjuvant Chemotherapy in Patients of Stage II-III HR-positive/HER2-negative Breast Cancer

130 enrolled

Breast Neoplasms

NCT05189067 2022-01-12

Efficacy and Safety of Adjuvant Docetaxel and Trastuzumab in Stage I HER2-positive Breast Cancer

190 enrolled

HER2-positive Breast Cancer

NCT04736186 2021-02-03

Prevention and Treatment of Pyrrolitinib-associated Diarrhea

470 enrolled

Breast Neoplasms, Diarrhea

NCT04705909 2021-01-12

Efficacy of Statin Addition to Neoadjuvant Chemotherapy Protocols for Breast Cancer

Breast Neoplasms

NCT04387630 2020-06-11

Neoadjuvant Chemotherapy With or Without Metformin in Early Breast Cancer.

120 enrolled

Breast Neoplasms

NCT02759783 2019-08-21

CORE

BreastGenitourinaryThoracic

245 enrolled

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms

NCT01907529 2019-08-09

TENDENCY

300 enrolled

Breast Neoplasms

NCT03606369 2018-07-30

Effectiveness and Quality of Life Analysis of Palonosetron Against Ondansetron Combined With Dexamethasone and Fosaprepitant in Prevention of Acute and Delayed Emesis Associated to Chemotherapy Moderate and Highly Emetogenic in Breast Cancer.

560 enrolled

Breast Neoplasms

NCT03507465 2018-04-25

Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer

290 enrolled

Breast Neoplasms

NCT03491410 2018-04-09

Breast Cancer Active Surveillance, Alternative Option, Aspirin Included

Breast Neoplasms, Neoplasm Metastasis

NCT03423849 2018-02-06

The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage Therapy

200 enrolled

Breast Neoplasms

NCT03349177 2017-11-21

Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy

200 enrolled

Breast Neoplasms

NCT01782274 2017-10-12

Proteome-based Immunotherapy of Brain Metastases From Breast Cancer

BreastCNS

Brain Neoplasms, Breast Neoplasms, Neoplasm Metastasis

NCT03275727 2017-09-08

INNOVBC

128 enrolled

Breast Neoplasms

NCT03085368 2017-07-28

A Randomized Controlled Trial of HER-2 Positive Breast Cancer Patients Treated With Lapatinib vs Herceptin

482 enrolled

Breast Neoplasms

NCT01557478 2015-01-08

MIQOL-B

166 enrolled

Breast Neoplasms, Pain

NCT02132000 2014-05-06

Efficacy and Tolerability of Toremifene or Tamoxifen Therapy in Premenopausal Estrogen and Progesterone Receptor Positive Breast Cancer Patients

3,036 enrolled

Breast Cancer Patients in Premenopausal

NCT01648608 2012-08-03

Efficacy and Safety of TAC and Exemestane as Neoadjuvant Chemotherapy in the Postmenopausal Women With Breast Cancer

600 enrolled

Breast Neoplasms

NCT01647672 2012-07-25

Efficacy and Safety With Albumin-bound Paclitaxel (Abraxane) in the TAC as Neoadjuvant Chemotherapy in Breast Cancer

Breast Neoplasms

NCT01415336 2011-08-11

AX Versus AC as Adjuvant Treatment for Node-Negative Breast Cancer

300 enrolled

Breast Neoplasms

NCT00525642 2007-09-06

Study of Suitable Schedule of Docetaxel,Anthracycline and Cyclophosphamide in Adjuvant Therapy of Beast Cancer

603 enrolled